VIVO logo

Meridian Bioscience (VIVO) Free Cash Flow

Annual FCF

$73.75 M
+$25.19 M+51.89%

September 30, 2022

Summary

Performance

1-Year Change

+51.89%

3-Year Change

+127.77%

5-Year Change

+99.92%

15-Year Change

+99.92%

VIVO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$73.75 M
VIVO annual free cash flow is currently at an all-time high

3-Year Low

$48.55 M
VIVO annual free cash flow is currently +51.89% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVOcash flowmetrics:

Annual CFO

$82.36 M
VIVO annual cash flow from operations is $82.36 million

Annual CFF

-$34.30 M
VIVO annual cash flow from financing activities is -$34.30 million

Annual CFI

-$11.12 M
VIVO annual cash flow from investing activities is -$11.12 million

Annual CAPEX

$8.62 M
VIVO annual capital expenditures is $8.62 million

Quarterly FCF

-$1.49 M
-$13.93 M-111.97%

September 30, 2022

Summary

Performance

3-Month Change

-111.97%

1-Year Change

-111.85%

3-Year Change

-120.77%

5-Year Change

-119.11%

VIVO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$33.85 M
VIVO quarterly free cash flow is currently -104.40% below its historical high of $33.85 million

3-Year Low

-$1.49 M
VIVO quarterly free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOcash flowmetrics:

Quarterly CFO

$1.99 M
VIVO quarterly cash flow from operations is $1.99 million

Quarterly CFF

-$472.00 K
VIVO quarterly cash flow from financing activities is -$472.00 thousand

Quarterly CFI

-$2.23 M
VIVO quarterly cash flow from investing activities is -$2.23 million

Quarterly CAPEX

$3.48 M
VIVO quarterly capital expenditures is $3.48 million

TTM FCF

$73.75 M
-$14.06 M-16.02%

September 30, 2022

Summary

Performance

3-Month Change

-16.02%

1-Year Change

+51.89%

3-Year Change

+154.74%

5-Year Change

+154.74%

VIVO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$87.81 M
VIVO TTM free cash flow is currently -16.02% below its historical high of $87.81 million

3-Year Low

$59.37 M
VIVO TTM free cash flow is currently +24.22% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOcash flowmetrics:

TTM CFO

$82.36 M
VIVO TTM cash flow from operations is $82.36 million

TTM CFF

-$34.30 M
VIVO TTM cash flow from financing activities is -$34.30 million

TTM CFI

-$11.12 M
VIVO TTM cash flow from investing activities is -$11.12 million

TTM CAPEX

$8.62 M
VIVO TTM capital expenditures is $8.62 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

$73.75 M
VIVO annual free cash flow is $73.75 million

Annual CFO

$82.36 M
VIVO annual cash flow from operations is $82.36 million

Annual CAPEX

$8.62 M
VIVO annual capital expenditures is $8.62 million

VIVO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+51.9%-111.8%+51.9%
3 y3 years+127.8%-120.8%+154.7%
5 y5 years+99.9%-119.1%+154.7%

VIVO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-34.2%-104.4%at low-16.0%-19.5%
5 y5-yearat high-56.1%-104.4%at low-16.0%-62.6%
alltimeall timeat high-116.7%-104.4%+1091.3%-16.0%-122.5%

Meridian Bioscience Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2022
$73.75 M(+51.9%)
-$1.49 M(-112.0%)
$73.75 M(-16.0%)
Jun 2022
-
$12.44 M(-57.0%)
$87.81 M(+7.3%)
Mar 2022
-
$28.95 M(-14.5%)
$81.81 M(+37.8%)
Dec 2021
-
$33.85 M(+169.2%)
$59.37 M(+22.3%)
Sep 2021
$48.55 M(+8.7%)
$12.57 M(+95.2%)
$48.55 M(-5.6%)
Jun 2021
-
$6.44 M(-0.9%)
$51.45 M(-14.3%)
Mar 2021
-
$6.50 M(-71.8%)
$60.04 M(-4.3%)
Dec 2020
-
$23.04 M(+48.9%)
$62.76 M(+40.5%)
Sep 2020
$44.68 M(+38.0%)
$15.47 M(+2.9%)
$44.68 M(+22.8%)
Jun 2020
-
$15.04 M(+63.0%)
$36.38 M(+31.8%)
Mar 2020
-
$9.22 M(+86.4%)
$27.61 M(-4.6%)
Dec 2019
-
$4.95 M(-31.0%)
$28.95 M(-10.6%)
Sep 2019
$32.38 M(+5.9%)
$7.17 M(+14.5%)
$32.38 M(-8.9%)
Jun 2019
-
$6.26 M(-40.7%)
$35.55 M(-6.1%)
Mar 2019
-
$10.56 M(+26.1%)
$37.84 M(+8.0%)
Dec 2018
-
$8.38 M(-19.0%)
$35.03 M(+14.5%)
Sep 2018
$30.59 M(-17.1%)
$10.34 M(+20.8%)
$30.59 M(+9.1%)
Jun 2018
-
$8.56 M(+10.6%)
$28.04 M(+9.1%)
Mar 2018
-
$7.74 M(+96.6%)
$25.71 M(-12.0%)
Dec 2017
-
$3.94 M(-49.5%)
$29.22 M(-20.8%)
Sep 2017
$36.89 M(+11.0%)
$7.80 M(+25.2%)
$36.89 M(-5.4%)
Jun 2017
-
$6.23 M(-44.7%)
$38.99 M(-0.4%)
Mar 2017
-
$11.26 M(-3.0%)
$39.16 M(+16.8%)
Dec 2016
-
$11.60 M(+17.1%)
$33.52 M(+0.9%)
Sep 2016
$33.22 M(-12.7%)
$9.90 M(+54.9%)
$33.22 M(-2.1%)
Jun 2016
-
$6.39 M(+13.8%)
$33.95 M(-9.5%)
Mar 2016
-
$5.62 M(-50.3%)
$37.50 M(+8.4%)
Dec 2015
-
$11.30 M(+6.3%)
$34.59 M(-9.1%)
Sep 2015
$38.05 M(+21.7%)
$10.63 M(+6.9%)
$38.05 M(-6.6%)
Jun 2015
-
$9.94 M(+266.1%)
$40.72 M(+3.3%)
Mar 2015
-
$2.72 M(-81.6%)
$39.42 M(+0.6%)
Dec 2014
-
$14.75 M(+10.9%)
$39.21 M(+25.4%)
Sep 2014
$31.26 M(-24.1%)
$13.30 M(+53.8%)
$31.26 M(+8.5%)
Jun 2014
-
$8.65 M(+246.3%)
$28.81 M(-2.4%)
Mar 2014
-
$2.50 M(-63.3%)
$29.51 M(-8.7%)
Dec 2013
-
$6.81 M(-37.3%)
$32.32 M(-21.5%)
Sep 2013
$41.16 M(+9.4%)
$10.86 M(+16.1%)
$41.16 M(+2.1%)
Jun 2013
-
$9.35 M(+76.1%)
$40.31 M(-5.9%)
Mar 2013
-
$5.31 M(-66.1%)
$42.85 M(-0.6%)
Dec 2012
-
$15.64 M(+56.2%)
$43.10 M(+14.6%)
Sep 2012
$37.61 M(+182.7%)
$10.01 M(-15.8%)
$37.61 M(+17.7%)
Jun 2012
-
$11.88 M(+113.8%)
$31.96 M(+33.5%)
Mar 2012
-
$5.56 M(-45.3%)
$23.95 M(+92.6%)
Dec 2011
-
$10.15 M(+132.6%)
$12.43 M(-6.6%)
Sep 2011
$13.30 M(-49.8%)
$4.37 M(+12.8%)
$13.30 M(-13.9%)
Jun 2011
-
$3.87 M(-165.0%)
$15.45 M(-9.6%)
Mar 2011
-
-$5.96 M(-154.0%)
$17.10 M(-32.3%)
Dec 2010
-
$11.03 M(+69.4%)
$25.27 M(-4.8%)
Sep 2010
$26.53 M(-7.7%)
$6.51 M(+18.0%)
$26.53 M(-0.8%)
Jun 2010
-
$5.52 M(+149.3%)
$26.73 M(-17.3%)
Mar 2010
-
$2.21 M(-82.0%)
$32.31 M(-8.9%)
Dec 2009
-
$12.29 M(+83.1%)
$35.47 M(+23.4%)
Sep 2009
$28.74 M(+17.0%)
$6.71 M(-39.5%)
$28.74 M(+1.0%)
Jun 2009
-
$11.10 M(+106.6%)
$28.46 M(+14.9%)
Mar 2009
-
$5.37 M(-3.4%)
$24.76 M(+11.0%)
Dec 2008
-
$5.56 M(-13.6%)
$22.30 M(-9.2%)
Sep 2008
$24.56 M(+6.2%)
$6.43 M(-13.0%)
$24.56 M(-2.8%)
Jun 2008
-
$7.40 M(+154.4%)
$25.25 M(-8.2%)
Mar 2008
-
$2.91 M(-62.8%)
$27.50 M(+2.0%)
Dec 2007
-
$7.81 M(+9.6%)
$26.97 M(+16.6%)
Sep 2007
$23.13 M(+22.3%)
$7.13 M(-26.0%)
$23.13 M(+0.2%)
Jun 2007
-
$9.64 M(+305.7%)
$23.09 M(+10.8%)
Mar 2007
-
$2.38 M(-40.2%)
$20.84 M(+0.2%)
Dec 2006
-
$3.97 M(-44.0%)
$20.80 M(+10.0%)
Sep 2006
$18.91 M
$7.10 M(-4.0%)
$18.91 M(+26.4%)
Jun 2006
-
$7.39 M(+215.8%)
$14.97 M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2006
-
$2.34 M(+12.2%)
$14.93 M(+3.1%)
Dec 2005
-
$2.09 M(-33.8%)
$14.49 M(-7.1%)
Sep 2005
$15.59 M(+51.8%)
$3.15 M(-57.2%)
$15.59 M(-1.4%)
Jun 2005
-
$7.36 M(+288.2%)
$15.81 M(+19.9%)
Mar 2005
-
$1.90 M(-40.5%)
$13.18 M(+26.9%)
Dec 2004
-
$3.19 M(-5.7%)
$10.39 M(+1.1%)
Sep 2004
$10.27 M(-2.6%)
$3.38 M(-28.6%)
$10.27 M(+21.9%)
Jun 2004
-
$4.73 M(-624.1%)
$8.42 M(+32.5%)
Mar 2004
-
-$902.00 K(-129.4%)
$6.35 M(-25.9%)
Dec 2003
-
$3.07 M(+100.5%)
$8.58 M(-18.6%)
Sep 2003
$10.54 M(+34.0%)
$1.53 M(-42.5%)
$10.54 M(-13.6%)
Jun 2003
-
$2.66 M(+101.1%)
$12.21 M(+3.0%)
Mar 2003
-
$1.32 M(-73.7%)
$11.86 M(+10.6%)
Dec 2002
-
$5.03 M(+57.4%)
$10.72 M(+36.3%)
Sep 2002
$7.87 M(+16.0%)
$3.19 M(+38.4%)
$7.87 M(+11.8%)
Jun 2002
-
$2.31 M(+1127.7%)
$7.03 M(-0.5%)
Mar 2002
-
$188.00 K(-91.4%)
$7.07 M(-15.8%)
Dec 2001
-
$2.17 M(-8.0%)
$8.39 M(+23.8%)
Sep 2001
$6.78 M(+479.4%)
$2.36 M(+0.9%)
$6.78 M(+53.6%)
Jun 2001
-
$2.34 M(+55.1%)
$4.41 M(+8.2%)
Mar 2001
-
$1.51 M(+169.3%)
$4.08 M(+150.2%)
Dec 2000
-
$561.00 K(<-9900.0%)
$1.63 M(+39.4%)
Sep 2000
$1.17 M(-109.5%)
-$2000.00(-100.1%)
$1.17 M(-107.1%)
Jun 2000
-
$2.01 M(-314.3%)
-$16.58 M(+1152.1%)
Mar 2000
-
-$938.00 K(-1038.0%)
-$1.32 M(+611.8%)
Dec 1999
-
$100.00 K(-100.6%)
-$186.00 K(-98.5%)
Sep 1999
-$12.29 M(-319.4%)
-$17.75 M(-202.8%)
-$12.29 M(-269.1%)
Jun 1999
-
$17.26 M(+8532.0%)
$7.26 M(-184.5%)
Mar 1999
-
$200.00 K(-101.7%)
-$8.60 M(+2.4%)
Dec 1998
-
-$12.00 M(-766.7%)
-$8.40 M(-250.0%)
Sep 1998
$5.60 M(+14.3%)
$1.80 M(+28.6%)
$5.60 M(-5.1%)
Jun 1998
-
$1.40 M(+250.0%)
$5.90 M(+25.5%)
Mar 1998
-
$400.00 K(-80.0%)
$4.70 M(+27.0%)
Dec 1997
-
$2.00 M(-4.8%)
$3.70 M(-24.5%)
Sep 1997
$4.90 M(+32.4%)
$2.10 M(+950.0%)
$4.90 M(+63.3%)
Jun 1997
-
$200.00 K(-133.3%)
$3.00 M(-18.9%)
Mar 1997
-
-$600.00 K(-118.8%)
$3.70 M(-19.6%)
Dec 1996
-
$3.20 M(+1500.0%)
$4.60 M(+24.3%)
Sep 1996
$3.70 M(+825.0%)
$200.00 K(-77.8%)
$3.70 M(-5.1%)
Jun 1996
-
$900.00 K(+200.0%)
$3.90 M(+2.6%)
Mar 1996
-
$300.00 K(-87.0%)
$3.80 M(+2.7%)
Dec 1995
-
$2.30 M(+475.0%)
$3.70 M(+825.0%)
Sep 1995
$400.00 K(-86.2%)
$400.00 K(-50.0%)
$400.00 K(-66.7%)
Jun 1995
-
$800.00 K(+300.0%)
$1.20 M(-25.0%)
Mar 1995
-
$200.00 K(-120.0%)
$1.60 M(+23.1%)
Dec 1994
-
-$1.00 M(-183.3%)
$1.30 M(-55.2%)
Sep 1994
$2.90 M(+107.1%)
$1.20 M(0.0%)
$2.90 M(+45.0%)
Jun 1994
-
$1.20 M(-1300.0%)
$2.00 M(+42.9%)
Mar 1994
-
-$100.00 K(-116.7%)
$1.40 M(-22.2%)
Dec 1993
-
$600.00 K(+100.0%)
$1.80 M(+28.6%)
Sep 1993
$1.40 M(-300.0%)
$300.00 K(-50.0%)
$1.40 M(-17.6%)
Jun 1993
-
$600.00 K(+100.0%)
$1.70 M(+112.5%)
Mar 1993
-
$300.00 K(+50.0%)
$800.00 K(+300.0%)
Dec 1992
-
$200.00 K(-66.7%)
$200.00 K(-128.6%)
Sep 1992
-$700.00 K(-800.0%)
$600.00 K(-300.0%)
-$700.00 K(-41.7%)
Jun 1992
-
-$300.00 K(0.0%)
-$1.20 M(+33.3%)
Mar 1992
-
-$300.00 K(-57.1%)
-$900.00 K(+200.0%)
Dec 1991
-
-$700.00 K(-800.0%)
-$300.00 K(-400.0%)
Sep 1991
$100.00 K(-83.3%)
$100.00 K(>+9900.0%)
$100.00 K(0.0%)
Jun 1991
-
$0.00(-100.0%)
$100.00 K(-80.0%)
Mar 1991
-
$300.00 K(-200.0%)
$500.00 K(+150.0%)
Dec 1990
-
-$300.00 K(-400.0%)
$200.00 K(-66.7%)
Sep 1990
$600.00 K
$100.00 K(-75.0%)
$600.00 K(+20.0%)
Jun 1990
-
$400.00 K(>+9900.0%)
$500.00 K(+400.0%)
Mar 1990
-
$0.00(-100.0%)
$100.00 K(0.0%)
Dec 1989
-
$100.00 K
$100.00 K

FAQ

  • What is Meridian Bioscience annual free cash flow?
  • What is the all time high annual FCF for Meridian Bioscience?
  • What is Meridian Bioscience annual FCF year-on-year change?
  • What is Meridian Bioscience quarterly free cash flow?
  • What is the all time high quarterly FCF for Meridian Bioscience?
  • What is Meridian Bioscience quarterly FCF year-on-year change?
  • What is Meridian Bioscience TTM free cash flow?
  • What is the all time high TTM FCF for Meridian Bioscience?
  • What is Meridian Bioscience TTM FCF year-on-year change?

What is Meridian Bioscience annual free cash flow?

The current annual FCF of VIVO is $73.75 M

What is the all time high annual FCF for Meridian Bioscience?

Meridian Bioscience all-time high annual free cash flow is $73.75 M

What is Meridian Bioscience annual FCF year-on-year change?

Over the past year, VIVO annual free cash flow has changed by +$25.19 M (+51.89%)

What is Meridian Bioscience quarterly free cash flow?

The current quarterly FCF of VIVO is -$1.49 M

What is the all time high quarterly FCF for Meridian Bioscience?

Meridian Bioscience all-time high quarterly free cash flow is $33.85 M

What is Meridian Bioscience quarterly FCF year-on-year change?

Over the past year, VIVO quarterly free cash flow has changed by -$14.06 M (-111.85%)

What is Meridian Bioscience TTM free cash flow?

The current TTM FCF of VIVO is $73.75 M

What is the all time high TTM FCF for Meridian Bioscience?

Meridian Bioscience all-time high TTM free cash flow is $87.81 M

What is Meridian Bioscience TTM FCF year-on-year change?

Over the past year, VIVO TTM free cash flow has changed by +$25.19 M (+51.89%)